Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

July 30, 2018

Eagle Pharmaceuticals Inc. v. Eli Lilly and Company

Track this case

Case Number:

1:18-cv-01121

Court:

Delaware

Nature of Suit:

Anti-Trust

Judge:

Mitchell S. Goldberg

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. December 17, 2019

    Eagle, Eli Lilly Drop Dueling Cancer Drug Patent Claims

    Eagle Pharmaceuticals has agreed to drop its lingering antitrust claims over Eli Lilly's chemotherapy drug Alimta after the companies reached a settlement ending patent litigation and allowing Eagle to launch a branded alternative in 2022.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login